These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26371080)

  • 1. The double trouble of metabolic diseases: the diabetes-cancer link.
    Tudzarova S; Osman MA
    Mol Biol Cell; 2015 Sep; 26(18):3129-39. PubMed ID: 26371080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and cancer.
    Zelenko Z; Gallagher EJ
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):167-85. PubMed ID: 24582097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.
    Coope A; Torsoni AS; Velloso LA
    Eur J Endocrinol; 2016 May; 174(5):R175-87. PubMed ID: 26646937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
    Roos J; Grösch S; Werz O; Schröder P; Ziegler S; Fulda S; Paulus P; Urbschat A; Kühn B; Maucher I; Fettel J; Vorup-Jensen T; Piesche M; Matrone C; Steinhilber D; Parnham MJ; Maier TJ
    Pharmacol Ther; 2016 Jan; 157():43-64. PubMed ID: 26549540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR3 and its roles in the pathogenesis of type 2 diabetes.
    Sepehri Z; Kiani Z; Javadian F; Akbar Nasiri A; Kohan F; Sepehrikia S; Javan Siamardi S; Aali H; Daneshvar H; Kennedy D
    Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):46-50. PubMed ID: 26081813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-Based Association Study of Obesity and Type 2 Diabetes with Gene Expression Profiles.
    Zhang S; Wang B; Shi J; Li J
    Biomed Res Int; 2015; 2015():619730. PubMed ID: 26273637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT signaling: an emerging mediator of cancer cell metabolism?
    Sherwood V
    Mol Cell Biol; 2015 Jan; 35(1):2-10. PubMed ID: 25348713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.
    García-Jiménez C; García-Martínez JM; Chocarro-Calvo A; De la Vieja A
    J Mol Endocrinol; 2014 Feb; 52(1):R51-66. PubMed ID: 24049067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
    Chevalier S; Farsijani S
    Appl Physiol Nutr Metab; 2014 Jun; 39(6):643-53. PubMed ID: 24869969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms.
    Ben-Shmuel S; Rostoker R; Scheinman EJ; LeRoith D
    Handb Exp Pharmacol; 2016; 233():355-72. PubMed ID: 25903410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
    Cao Y; Li Y; Kim J; Ren Y; Himmeldirk K; Liu Y; Qian Y; Liu F; Chen X
    J Mol Endocrinol; 2013; 51(1):15-26. PubMed ID: 23549408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.
    Gallagher EJ; LeRoith D
    Physiol Rev; 2015 Jul; 95(3):727-48. PubMed ID: 26084689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landscape of the relationship between type 2 diabetes and coronary heart disease through an integrated gene network analysis.
    Dong C; Tang L; Liu Z; Bu S; Liu Q; Wang Q; Mai Y; Wang DW; Duan S
    Gene; 2014 Apr; 539(1):30-6. PubMed ID: 24508273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Aβ production prompts the onset of glucose intolerance and insulin resistance.
    Jiménez-Palomares M; Ramos-Rodríguez JJ; López-Acosta JF; Pacheco-Herrero M; Lechuga-Sancho AM; Perdomo G; García-Alloza M; Cózar-Castellano I
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1373-80. PubMed ID: 22414803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes.
    Barry JC; Shakibakho S; Durrer C; Simtchouk S; Jawanda KK; Cheung ST; Mui AL; Little JP
    Sci Rep; 2016 Feb; 6():21244. PubMed ID: 26883847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.
    Cohen DH; LeRoith D
    Endocr Relat Cancer; 2012 Oct; 19(5):F27-45. PubMed ID: 22593429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits.
    De Silva NM; Frayling TM
    Curr Opin Lipidol; 2010 Feb; 21(1):44-50. PubMed ID: 19956073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.